Earlier this week, National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, spoke at the Bundled Payments Summit in Washington, DC, where he and a panel of experts addressed some of the challenges related to our evolving health care payment and delivery environment.
We caught up with Dr. Dubois and asked him about how the shift from a fee-for-service system to one that is performance-based is impacting consumers. In our interview, he explains the issues with developing a cost-effective system, ensuring that patients have access to optimal treatments, and putting the right quality measures in place.